A Zelnorm Attorney Can Help
After studies revealed that patients taking Zelnorm were eight times more likely to suffer a heart attack, stroke or other cardiovascular side effects, Novartis Pharmaceuticals issued a Zelnorm withdrawal in March 2007 at the request of the Food and Drug Administration. The FDA says that Novartis is planning to issue a Zelnorm recall, although no date has been announced.
300% increased risk
In addition, earlier studies linked Zelnorm to a three-fold increase in the risk of ovarian cysts and a dramatic increase in the risk of gall bladder or other abdominal problems. During a study investigating the side effects of Zelnorm, patients taking the drug needed surgery to treat gall bladder or other problems five times as often as those who were given a placebo.
At least one patient treated with Zelnorm died after using the drug, and many more have suffered injuries. As more and more of the 4.7 million women who suffer from irritable bowel syndrome learn that symptoms they have suffered may have been caused by Zelnorm side effects, the number of injuries and deaths linked to the drug may increase substantially.
Because Novartis' withdrawal of Zelnorm is so recent, a full understanding of the danger of Zelnorm side effects has only begun to emerge.
